0001179110-13-009032.txt : 20130524
0001179110-13-009032.hdr.sgml : 20130524
20130524075148
ACCESSION NUMBER: 0001179110-13-009032
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130523
FILED AS OF DATE: 20130524
DATE AS OF CHANGE: 20130524
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SANTINI GINO
CENTRAL INDEX KEY: 0001276038
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10865
FILM NUMBER: 13870196
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMAG PHARMACEUTICALS INC.
CENTRAL INDEX KEY: 0000792977
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 042742593
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 HAYDEN AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 6174983300
MAIL ADDRESS:
STREET 1: 100 HAYDEN AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
FORMER COMPANY:
FORMER CONFORMED NAME: ADVANCED MAGNETICS INC
DATE OF NAME CHANGE: 19920703
4
1
edgar.xml
FORM 4 -
X0306
4
2013-05-23
0
0000792977
AMAG PHARMACEUTICALS INC.
AMAG
0001276038
SANTINI GINO
100 HAYDEN AVENUE
LEXINGTON
MA
02421
1
0
0
0
Common Stock
2013-05-23
4
A
0
2300
A
5075
D
Stock Option (Right to Buy)
21.94
2013-05-23
4
A
0
3800
A
2023-05-23
Common Stock
3800
3800
D
Each restricted stock unit represents a contingent right to receive one share of Common Stock of AMAG Pharmaceuticals, Inc. (the "Issuer").
These shares of Common Stock are issuable pursuant to a grant of restricted stock units pursuant to the Issuer's Third Amended and Restated 2007 Equity Incentive Plan (the "Plan") that will vest in twelve equal monthly installments over one year from the date of grant, however, delivery of the shares is deferred until the earlier of (a) three years from the date of grant and (b) the date of the director's separation from service to the Issuer.
Not applicable.
This total includes 2,775 unsettled restricted stock units previously reported in Table II.
Grant of stock option pursuant to the Plan. This option will vest and become exercisable in twelve equal monthly installments over one year from the date of grant.
Nancy R. Smith, attorney-in-fact
2013-05-24